OBJECTIVE: To investigate the histopathology of the arachnoid granulations in patients with HIV-associated cryptococcal meningitis and correlate the findings with clinical data, in particular cerebrospinal fluid (CSF) opening pressure. DESIGN: Case series. METHODS: Postmortems were requested on patients dying during initial hospitalization with HIV-associated cryptococcal meningitis. RESULTS: Five postmortems were performed. Large numbers of cryptococcal cells were seen within the arachnoid granulations. The number of fungal cells correlated with CSF pressure. Inflammatory cell infiltrates and disruption of the normal architecture of the granulations were also observed. CONCLUSION: The study provides the first direct evidence supporting the obstruction to CSF reabsorption at the level of the arachnoid granulations as the main mechanism underlying the development of raised CSF pressure in HIV-associated cryptococcal meningitis.
OBJECTIVE: To investigate the histopathology of the arachnoid granulations in patients with HIV-associated cryptococcal meningitis and correlate the findings with clinical data, in particular cerebrospinal fluid (CSF) opening pressure. DESIGN: Case series. METHODS: Postmortems were requested on patients dying during initial hospitalization with HIV-associated cryptococcal meningitis. RESULTS: Five postmortems were performed. Large numbers of cryptococcal cells were seen within the arachnoid granulations. The number of fungal cells correlated with CSF pressure. Inflammatory cell infiltrates and disruption of the normal architecture of the granulations were also observed. CONCLUSION: The study provides the first direct evidence supporting the obstruction to CSF reabsorption at the level of the arachnoid granulations as the main mechanism underlying the development of raised CSF pressure in HIV-associated cryptococcal meningitis.
Authors: M S Saag; R J Graybill; R A Larsen; P G Pappas; J R Perfect; W G Powderly; J D Sobel; W E Dismukes Journal: Clin Infect Dis Date: 2000-04-20 Impact factor: 9.079
Authors: J R Graybill; J Sobel; M Saag; C van Der Horst; W Powderly; G Cloud; L Riser; R Hamill; W Dismukes Journal: Clin Infect Dis Date: 2000-01 Impact factor: 9.079
Authors: Tihana Bicanic; Annemarie E Brouwer; Graeme Meintjes; Kevin Rebe; Direk Limmathurotsakul; Wirongrong Chierakul; Praprit Teparrakkul; Angela Loyse; Nicholas J White; Robin Wood; Shabbar Jaffar; Thomas Harrison Journal: AIDS Date: 2009-03-27 Impact factor: 4.177
Authors: L de Vedia; A Arechavala; M I Calderón; E Maiolo; A Rodríguez; N Lista; E Di Virgilio; J C Cisneros; R Prieto Journal: Infection Date: 2013-12 Impact factor: 3.553
Authors: Peter R Williamson; Joseph N Jarvis; Anil A Panackal; Matthew C Fisher; Síle F Molloy; Angela Loyse; Thomas S Harrison Journal: Nat Rev Neurol Date: 2016-11-25 Impact factor: 42.937
Authors: Gordon J Smilnak; Lefko T Charalambous; Drew Cutshaw; Alykhan M Premji; Charles D Giamberardino; Christi G Ballard; Andrew P Bartuska; Tiffany U Ejikeme; Huaxin Sheng; Laura Zitella Verbick; Blake A Hedstrom; Promila C Pagadala; Aaron R McCabe; John R Perfect; Shivanand P Lad Journal: J Infect Dis Date: 2018-08-24 Impact factor: 5.226
Authors: Edward R Cachay; Joseph Caperna; Amy M Sitapati; Hamta Jafari; Sean Kandel; William C Mathews Journal: AIDS Res Ther Date: 2010-08-03 Impact factor: 2.250